DHA Vegan Algae
Natural health product licensed in Canada
- Other names
- DHA Vegetarian Algae
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 80023491
- Status
- Active licence
- Licence date
- 25 January 2011
- Revision date
- 19 March 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
triglycérides à chaînes moyennes, Lécithine, Eau, Modified food starch, Glycérine, Palmitate d'ascorbyle, Extrait de romarin, Carraghénine, Sorbitol, Huile de tournesol, Mélange de concentré de tocophérols
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 10 years | 3 Capsule | Not specified |
| Pregnant and breastfeeding women | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 18 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of DHA (Omega-3 fatty acids) for the maintenance of good health. Reduces serum triglycerides. When used during pregnancy and breastfeeding, DHA supports healthy neural and vision development of an infant. Helps support cognitive health and brain function in an aging population. Helps improve brain function in healthy adults with age-related cognitive decline. Helps support cognitive health by improving memory and learning functions in an aging population. Helps to improve reading performance and behavior (restless-impulsive, oppositional, hyperactivity and mood swing) in underperforming children aged 6-10. Improves reading ability and some attention deficit hyperactivity (ADHD)-type behavioral symptoms (restless-impulsive, oppositional, hyperactivity and mood swing) in underperforming children aged 6-10. Clinically proven to improve reading ability in underperforming children aged 6-10.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80023491
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.